Nemes Balázs, Gámán György, Polak Wojciech G, Gelley Fanni, Hara Takanobu, Ono Shinichiro, Baimakhanov Zhassulan, Piros Laszlo, Eguchi Susumu
a Department of Organ Transplantation, Faculty of Medicine , Institute of Surgery, University of Debrecen , Debrecen , Hungary.
b Clinic of Transplantation and Surgery , Semmelweis University , Budapest , Hungary.
Expert Rev Gastroenterol Hepatol. 2016 Jul;10(7):827-39. doi: 10.1586/17474124.2016.1149061. Epub 2016 Mar 3.
The definition and factors of extended criteria donors have already been set; however, details of the various opinions still differ in many respects. In this review, we summarize the impact of these factors and their clinical relevance. Elderly livers must not be allocated for hepatitis C virus (HCV) positives, or patients with acute liver failure. In cases of markedly increased serum transaminases, donor hemodynamics is an essential consideration. A prolonged hypotension of the donor does not always lead to an increase in post-transplantation graft loss if post-OLT care is proper. Hypernatremia of less than 160 mEq/L is not an absolute contraindication to accept a liver graft per se. The presence of steatosis is an independent and determinant risk factor for the outcome. The gold standard of the diagnosis is the biopsy. This is recommended in all doubtful cases. The use of HCV+ grafts for HCV+ recipients is comparable in outcome. The leading risk factor for HCV recurrence is the actual RNA positivity of the donor. The presence of a proper anti-HBs level seems to protect from de novo HBV infection. A favourable outcome can be expected if a donation after cardiac death liver is transplanted in a favourable condition, meaning, a warm ischemia time < 30 minutes, cold ischemia time < 8-10 hours, and donor age 50-60 years. The pathway of organ quality assessment is to obtain the most relevant information (e.g. biopsy), consider the co-existing donor risk factors and the reserve capacity of the recipient, and avoid further technical issues.
扩大标准供体的定义和相关因素已经确定;然而,各种观点的细节在许多方面仍存在差异。在本综述中,我们总结了这些因素的影响及其临床相关性。老年肝脏不得分配给丙型肝炎病毒(HCV)阳性患者或急性肝衰竭患者。在血清转氨酶显著升高的情况下,供体血流动力学是一个重要的考虑因素。如果肝移植术后护理得当,供体长时间低血压并不一定会导致移植后移植物丢失增加。血清钠浓度低于160 mEq/L本身并非接受肝脏移植的绝对禁忌证。脂肪变性的存在是影响预后的一个独立且决定性的危险因素。诊断的金标准是活检。在所有可疑病例中均建议进行活检。将HCV阳性供肝用于HCV阳性受者,其预后相当。HCV复发的主要危险因素是供体实际RNA阳性。适当的抗-HBs水平似乎可预防新发HBV感染。如果在有利条件下移植心脏死亡后供肝,即热缺血时间<30分钟、冷缺血时间<8 - 10小时且供体年龄50 - 60岁,有望获得良好的预后。器官质量评估的途径是获取最相关的信息(如活检),考虑供体并存的危险因素和受者的储备能力,并避免进一步的技术问题。